Jelena Vekić

2.8k total citations · 1 hit paper
97 papers, 1.9k citations indexed

About

Jelena Vekić is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Clinical Biochemistry. According to data from OpenAlex, Jelena Vekić has authored 97 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Endocrinology, Diabetes and Metabolism, 35 papers in Surgery and 19 papers in Clinical Biochemistry. Recurrent topics in Jelena Vekić's work include Lipoproteins and Cardiovascular Health (25 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (22 papers) and Paraoxonase enzyme and polymorphisms (17 papers). Jelena Vekić is often cited by papers focused on Lipoproteins and Cardiovascular Health (25 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (22 papers) and Paraoxonase enzyme and polymorphisms (17 papers). Jelena Vekić collaborates with scholars based in Serbia, Italy and Slovenia. Jelena Vekić's co-authors include Aleksandra Zeljković, Vesna Spasojević‐Kalimanovska, Zorana Jelić‐Ivanović, Aleksandra Stefanović, Slavica Spasić, Jelena Kotur‐Stevuljević, Manfredi Rizzo, Nataša Bogavac‐Stanojević, Milica Miljković and Aleksandra Topić and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and British Journal Of Nutrition.

In The Last Decade

Jelena Vekić

91 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Obesity and dyslipidemia

2018 430 citations Jelena Vekić, Aleksandra Zeljković et al. Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jelena Vekić Serbia	23	566	546	355	352	306	97	1.9k
Aleksandra Zeljković Serbia	23	594 1.0×	583 1.1×	341 1.0×	312 0.9×	310 1.0×	91	1.8k
Óscar Pérez‐Méndez Mexico	23	547 1.0×	429 0.8×	290 0.8×	410 1.2×	327 1.1×	127	1.9k
E.R. Nakandakare Brazil	26	644 1.1×	688 1.3×	301 0.8×	400 1.1×	232 0.8×	104	1.8k
Garry X. Shen Canada	30	394 0.7×	396 0.7×	302 0.9×	534 1.5×	244 0.8×	99	2.3k
Sergio Martínez‐Hervás Spain	23	438 0.8×	443 0.8×	290 0.8×	379 1.1×	225 0.7×	117	1.6k
Seok Joon Shin South Korea	28	389 0.7×	391 0.7×	335 0.9×	738 2.1×	332 1.1×	89	2.6k
Slavica Spasić Serbia	27	352 0.6×	340 0.6×	231 0.7×	320 0.9×	246 0.8×	82	1.7k
Massimo Boemi Italy	23	1.1k 1.9×	417 0.8×	264 0.7×	469 1.3×	405 1.3×	71	2.4k
Donatella Siepi Italy	25	529 0.9×	528 1.0×	378 1.1×	309 0.9×	671 2.2×	70	1.9k
Stefano Rizza Italy	27	357 0.6×	264 0.5×	454 1.3×	592 1.7×	405 1.3×	82	2.3k

Countries citing papers authored by Jelena Vekić

Since Specialization

Citations

This map shows the geographic impact of Jelena Vekić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jelena Vekić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jelena Vekić more than expected).

Fields of papers citing papers by Jelena Vekić

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jelena Vekić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jelena Vekić. The network helps show where Jelena Vekić may publish in the future.

Co-authorship network of co-authors of Jelena Vekić

This figure shows the co-authorship network connecting the top 25 collaborators of Jelena Vekić. A scholar is included among the top collaborators of Jelena Vekić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jelena Vekić. Jelena Vekić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vekić, Jelena, Aleksandra Stefanović, Željko Miković, et al.. (2025). Monocyte/HDL-cholesterol ratio as an early prognostic marker of pregnancy complications development. SHILAP Revista de lepidopterología. 75(1). 55–69. 1 indexed citations

Stefanović, Aleksandra, Aleksandra Zeljković, Tamara Gojković, et al.. (2025). Unraveling sphingolipid dynamics in late-onset preeclampsia: insights from lipidomic analysis. Biochemia Medica. 35(1). 119–128. 1 indexed citations

Sopić, Miron, et al.. (2023). The influence of Klotho protein and prooxidant–antioxidant balance combination on the mortality of HD patients. International Urology and Nephrology. 56(2). 615–623. 1 indexed citations

Vekić, Jelena, Biljana Bufan, Khamis Al-Hashmi, et al.. (2023). The Role of Advanced Glycation End Products on Dyslipidemia. Metabolites. 13(1). 77–77. 16 indexed citations

Vekić, Jelena, Aleksandra Zeljković, Aleksandra Stefanović, et al.. (2022). Novel Pharmaceutical and Nutraceutical-Based Approaches for Cardiovascular Diseases Prevention Targeting Atherogenic Small Dense LDL. Pharmaceutics. 14(4). 825–825. 8 indexed citations

Vekić, Jelena, Aleksandra Zeljković, Arrigo F.G. Cicero, et al.. (2022). Atherosclerosis Development and Progression: The Role of Atherogenic Small, Dense LDL. Medicina. 58(2). 299–299. 74 indexed citations

Vekić, Jelena, Aleksandra Zeljković, Khalid Al‐Rasadi, et al.. (2022). A New Look at Novel Cardiovascular Risk Biomarkers: The Role of Atherogenic Lipoproteins and Innovative Antidiabetic Therapies. Metabolites. 12(2). 108–108. 22 indexed citations

Vekić, Jelena, Djuro Μacut, Svetlana Ignjatović, et al.. (2021). Overweight and obesity in polycystic ovary syndrome: association with inflammation, oxidative stress and dyslipidaemia. British Journal Of Nutrition. 128(4). 604–612. 18 indexed citations

Ninić, Ana, Miron Sopić, Marija Mihajlović, et al.. (2020). Transforming Growth Factor-β1 and Receptor for Advanced Glycation End Products Gene Expression and Protein Levels in Adolescents with Type 1 Diabetes Mellitus. Journal of Clinical Research in Pediatric Endocrinology. 13(1). 61–71. 4 indexed citations

10.

Zeljković, Aleksandra, Marija Mihajlović, Aleksandra Stefanović, et al.. (2020). Potential use of serum insulin‐like growth factor 1 and E‐cadherin as biomarkers of colorectal cancer. Colorectal Disease. 22(12). 2078–2086. 7 indexed citations

11.

Vuković, Rade, Aleksandra Zeljković, Biljana Bufan, et al.. (2019). Hashimoto Thyroiditis and Dyslipidemia in Childhood: A Review. Frontiers in Endocrinology. 10. 868–868. 15 indexed citations

12.

Ignjatović, Svetlana, Djuro Μacut, Jelena Kotur‐Stevuljević, et al.. (2018). Evaluation of a Summary Score for Dyslipidemia, Oxidative Stress and Inflammation (The Doi Score) in Women with Polycystic Ovary Syndrome and its Relationship with Obesity. Journal of Medical Biochemistry. 37(4). 476–485. 30 indexed citations

13.

Vekić, Jelena, Aleksandra Zeljković, Aleksandra Stefanović, Zorana Jelić‐Ivanović, & Vesna Spasojević‐Kalimanovska. (2018). Obesity and dyslipidemia. Metabolism. 92. 71–81. 430 indexed citations breakdown →

14.

Zeljković, Aleksandra, Nataša Bogavac‐Stanojević, Sanja Simić‐Ogrizović, et al.. (2014). Association of small, dense low-density lipoprotein cholesterol and galectin-3 in patients with chronic kidney disease. Scandinavian Journal of Clinical and Laboratory Investigation. 74(7). 637–643. 10 indexed citations

15.

Zeljković, Aleksandra, Jelena Vekić, Vesna Spasojević‐Kalimanovska, et al.. (2013). Smaller HDL particles are associated with absence of obstructive coronary artery disease in stable angina pectoris patients. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 51(3). 412–415. 3 indexed citations

16.

Vekić, Jelena, Aleksandra Zeljković, Zorana Jelić‐Ivanović, et al.. (2013). Association of glutathione-S-transferase gene polymorphism and lipoprotein subclasses in hemodialysis patients. Clinical Biochemistry. 47(6). 398–403. 3 indexed citations

17.

Zeljković, Aleksandra, Jelena Vekić, Vesna Spasojević‐Kalimanovska, et al.. (2012). Influence of hypertrigliceridemia on small, dense LDL and HDL particles in coronary artery disease. SCIndeks. 62(5). 461–474. 1 indexed citations

18.

Zeljković, Aleksandra, Nataša Bogavac‐Stanojević, Zorana Jelić‐Ivanović, et al.. (2008). Combined Effects of Small Apolipoprotein (a) Isoforms and Small, Dense LDL on Coronary Artery Disease Risk. Archives of Medical Research. 40(1). 29–35. 11 indexed citations

19.

Vekić, Jelena, Zorana Jelić‐Ivanović, Slavica Spasić, et al.. (2007). Association of oxidative stress and PON1 with LDL and HDL particle size in middle‐aged subjects. European Journal of Clinical Investigation. 37(9). 715–723. 43 indexed citations

20.

Topić, Aleksandra, et al.. (2007). Gender-related effect of apo E polymorphism on lipoprotein particle sizes in the middle-aged subjects. Clinical Biochemistry. 41(6). 361–367. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact